Preventive Beneficial Effect of an Aqueous Extract of Phyllanthus amarus Schum. and Thonn. (Euphorbiaceae) on DOCA-Salt–Induced Hypertension, Cardiac Hypertrophy and Dysfunction, and Endothelial Dysfunction in Rats

Background: Most cardiovascular troubleshot ultimately result of endothelial dysfunction-induced hypertension, an intractable problem in modern medicine. Fagara tessmannii, a shrub of the African rainforests found in Cameroon is traditionally used to treat heart diseases and hypertension. This study aimed to evaluate the preventive effects of the aqueous extract of F. tessmannii (AEFT) on arterial hypertension induced by NG-Nitro-L-arginine-methyl ester (L-NAME). Methods: Male Wistar rats received saline (5 mL.kg-1 , intraperitoneally) or L-NAME (25 mg.kg-1 ; intraperitoneally), L-NAME + AEFT (100 or 200 mg.kg-1 ; orally) or captopril (20 mg.kg-1 ; orally) for three weeks. Then, blood and pulse pressures (BP and PP), heart rate, lipid profile, kidney, liver and heart function markers and oxidative status were evaluated. Results: AEFT (100 and 200 mg.kg-1 ) prevented the increase in BP (p < 0.001), PP (p < 0.01), and heart rate (p < 0.05) induced by L-NAME. The extract has suppressed the decline of weight gain, visceral fat and triglyceridemia, decreased total cholesterol, increased HDL-cholesterol, and significantly reduced (p < 0.001) atherogenic and coronary risk indicators. AEFT also improved the liver, kidney and heart markers, nitrites levels and prevented TBARS enhancement as compared to the hypertensive group. The remodeling of the media and fibrosis process in coronaries were also prevented by the extract. Conclusion: These results suggest that AEFT can prevent endothelial dysfunction-induced hypertension, dyslipidemia and associated atherogenic risks, and oxidative stress induced by L-NAME.

Download Full-text

Antihyperglycemic, Antihyperlipidemic and Antioxidant Effects of Cotula cinerea (Del) in Normal and Streptozotocin-Induced Diabetic Rats

Endocrine Metabolic & Immune Disorders - Drug Targets ◽

10.2174/1871530320666200513081312 ◽

2020 ◽

Vol 20 (9) ◽

pp. 1504-1513 ◽

Cited By ~ 1

Author(s):

Ayoub Amssayef ◽

Mohamed Eddouks

Keyword(s):

Antioxidant Activity ◽

Glucose Tolerance ◽

Oral Administration ◽

Beneficial Effect ◽

Aqueous Extract ◽

Aerial Part ◽

Diabetic Rats ◽

Histopathological Analysis ◽

Phytochemical Screening ◽

Cotula Cinerea

Aims: The current investigation aimed to assess the antioxidant, antidiabetic and antilipidemic effects of the aqueous extract of aerial part of Cotula cinerea (C. cinerea). Background: Cotula cinerea (Del). which belongs to the Asteraceae family is commonly used traditionally for the treatment of diabetes. Objective: The objective of the study was to study the effect of the aqueous C. cinerea extract on glucose and lipid metabolism in normal and streptozotocin-induced diabetic rats using a single and repeated oral administration. Methods: A preliminary phytochemical screening and the quantification of phenolic and flavonoid contents as well as the antioxidant activity using three methods (DPPH, FRAP and ABTS) were carried out. The effect of a single and repeated (15 days of treatment) oral administration of the aqueous extract of aerial part of Cotula cinerea (AEAPCC) at a dose of 20 mg/kg on glucose and lipid profile was examined in normal and streptozotocin-induced diabetic rats. Additionally, histopathological examination of the pancreas and liver was carried out according to the Hematoxylin-Eosin method. Results: AEAPCC (20 mg/kg) showed a significant blood glucose-lowering activity in both normal and diabetic rats after a single and repeated oral administration during 15 days. The aqueous extract was also able to decrease the plasma triglycerides levels in both normal and diabetic rats after 15 days of oral treatment at a dose of 20 mg/Kg while no effect was observed on plasma cholesterol levels. In addition, the results show that AEAPCC exhibits an in vitro antioxidant activity using different tests. Histopathological analysis of the pancreas and liver of AEAPCC-treated diabetic rats has revealed that AEAPCC had a beneficial effect on the architecture of these organs while no improvement of glucose tolerance was noticed using the glucose tolerance test. Furthermore, the results showed that the extract is rich in several phytochemical compounds and exhibited an important antioxidant activity. The phytochemical screening revealed that AEAPCC contains polyphenolic compounds, flavonoids, tannins, alkaloids, saponins, quinones, sterols, terpenoids, anthroquinones and reducing sugars. Whereas, it is free from glycosides. Conclusion: In conclusion, this study demonstrates that Cotula cinerea possesses a beneficial effect on diabetes. Further investigations are required to study the mechanism of action of the antidiabetic effect of this plant.

Download Full-text

K V 1.3 channels are novel determinants of macrophage‐dependent endothelial dysfunction in angiotensin II‐induced hypertension in mice

British Journal of Pharmacology ◽

10.1111/bph.15407 ◽

2021 ◽

Vol 178 (8) ◽

pp. 1836-1854

Author(s):

Miguel A. Olivencia ◽

Marta Martínez‐Casales ◽

Diego A. Peraza ◽

Ana B. García‐Redondo ◽

Gema Mondéjar‐Parreño ◽

...

Keyword(s):

Angiotensin Ii ◽

Endothelial Dysfunction ◽

Induced Hypertension

Download Full-text

Allablanckia floribunda hypotensive activity on ethanol induced hypertension in rats

The Journal of Phytopharmacology ◽

10.31254/phyto.2018.7208 ◽

2018 ◽

Vol 7 (2) ◽

pp. 146-151

Author(s):

Danielle Claude Bilanda ◽

◽

Paul Désiré Djomeni Dzeufiet ◽

Orelien Mtopi Bopda ◽

Pierre Kamtchouing ◽

...

Keyword(s):

Blood Pressure ◽

Aqueous Extract ◽

Plant Extract ◽

Colorimetric Method ◽

Antioxidant Properties ◽

Radical Scavenging ◽

Hdl Cholesterol ◽

Hypotensive Activity ◽

Hypertensive Rats ◽

Induced Hypertension

Background: Chronic alcohol intake is related to hypertension. In the present work, we investigated the effect of Allablanckia floribunda Oliver (Clusiaceae) aqueous extract in alcohol-induced hypertensive rats and on related oxidative stress damages. Methods: Alcohol-induced hypertensive rats (AHR) was obtained by oral administration of ethanol (3 g/kg/day during 8 weeks). Blood pressure and heart rate were evaluated using the direct cannulation method. The effects of the extract on lipid profile as well as kidney and liver functions were studied. Free radical scavenging and antioxidant properties of the extract were evaluated by colorimetric method. The effects of A. floribunda were evaluated after 4 weeks of treatment with alcohol. Results: At the doses of 200 and 400 mg/kg/day, A. floribunda significantly decreased the mean blood pressure of AHR by 14.06 and 23.25 % respectively. Administration of the plant extract lead to the reduction of total cholesterol by 41.50% and 43.06%, HDL-cholesterol by 22.16 and 30.15% and artherogenic index by 69.78 and 74.43%, respectively at the doses of 200 and 400 mg/kg, as compared to untreated hypertensive rats. A. floribunda (200 and 400 mg/kg) decrease bilirubine (12.98 and 16.88%), urea (23.32% and 32.26 %), ALT (10.73 and 27.97%) and AST (29.80 and 42.22%) of treated AHR, respectively. The plant extract also reduced superoxide dismutase (SOD), malondialdehyde (MDA) and catalase and increased the reduced glutathione (GSH) concentration in aorta, heart, kidney and liver of AHR. Conclusion: These results suggest that the aqueous extract of A. floribunda possesses antioxidant and hypotensive activity in alcohol-induced hypertension

Download Full-text

Aqueous extract of Pterocarpus santalinoides DC stem bark prevents L-NAME-induced hypertension in rat

The Journal of Phytopharmacology ◽

10.31254/phyto.2021.10304 ◽

2021 ◽

Vol 10 (3) ◽

pp. 166-172

Author(s):

Chinte Yamjom Ramatou ◽

◽

Ngo Lemba Thom Esther ◽

Florence Tsofack Ngueguim ◽

Yannick Bekono Fouda ◽

...

Keyword(s):

Oxidative Stress ◽

Heart Rate ◽

Aqueous Extract ◽

Hdl Cholesterol ◽

Experimental Period ◽

Stem Bark ◽

Renal Markers ◽

Induced Hypertension ◽

And Oxidative Stress ◽

Pterocarpus Santalinoides

Background: Pterocarpus santalinoides stem bark is commonly used in Cameroonian medicine to treat many diseases including hypertension. Thus, this study was aimed to evaluate preventive effects of aqueous extract of Pterocarpus santalinoides (AEPS) stem bark on NG-Nitro-L-arginine-methyl ester (LNAME)-induced hypertension in rat. Methods: Normotensive rats received L-NAME (25 mg/kg intraperitoneally) concomitantly with AEPS (50, 100 and 200 mg/kg) or captopril (20 mg/kg) orally during 3 weeks. At the end of experimental period, arterial pressure and heart rate were recorded by invasive method. After sacrifice, blood, aorta and heart were harvested for biochemical analysis on homogenate. Results: Intraperitoneal injection of L-NAME induced in rat a significant increase (p < 0.001; p < 0.01; p < 0.05) of blood pressure, heart rate, malondialdehyde, total cholesterol, triglycerides, LDL-cholesterol, hepatic and renal markers functions. L-NAME also decreased significantly (p < 0.001; p < 0.01; p < 0.05) the levels of HDL-cholesterol, nitrites, glutathione, superoxide dismutase and catalase activities as compared to control rats. The AEPS prevented significantly the increase (p < 0.001) of hemodynamic parameters induced by L-NAME and various modifications of biochemical parameters (lipid profile, hepatic and renal markers functions) and oxidative stress markers evaluated. Conclusion: This study shows that the aqueous extract of Pterocarpus santalinoides prevents hypertension, dyslipidemia and oxidative stress induced by L-NAME in rat by attenuating endothelial dysfunction, liver and kidney’s damages

Download Full-text

Lead intoxication and beneficial effect of administering the aqueous extract of Artemisia absinthium on lipid metabolism and hypertension in male Wistar rats

10.38150/sajeb.11(2).p199-209 ◽

2021 ◽

Keyword(s):

Lipid Metabolism ◽

Beneficial Effect ◽

Aqueous Extract ◽

Wistar Rats ◽

Lead Intoxication ◽

Artemisia Absinthium ◽

Male Wistar Rats

Download Full-text

Abstract 252: 6ß-Hydroxytestosterone, A Cytochrome P450 1B1 Metabolite of Testosterone, Enhances Angiotensin II-Induced Pressor Effect in Male Mice

Hypertension ◽

10.1161/hyp.62.suppl_1.a252 ◽

2013 ◽

Vol 62 (suppl_1) ◽

Author(s):

Ajeeth K Pingili ◽

Brett L Jennings ◽

Nayaab S Khan ◽

Kafait U Malik

Keyword(s):

Cytochrome P450 ◽

Endothelial Dysfunction ◽

Ros Production ◽

Oxygen Species ◽

Pressor Effect ◽

Ang Ii ◽

Male Mice ◽

Cytochrome P450 1B1 ◽

Induced Hypertension ◽

Novel Target

Androgens have been implicated in the development of hypertension and castration minimizes the pressor effect of angiotensin (Ang) II. Previously we showed that Ang II-induced hypertension and associated pathophysiological changes are diminished in male cytochrome P450 (CYP) 1B1 gene disrupted mice. Since CYP1B1 metabolizes testosterone to 6β-hydroxytestosterone (6β-OHT); this study was conducted to determine its contribution in modulation of Ang II-induced hypertension. Eight weeks old male Cyp1b1+/+ and Cyp1b1-/- mice were either castrated or injected with 6β-OHT (15 μg/g, i.p. every 3rd day) or vehicle (DMSO, 50 μl), infused with Ang II (700 ng/kg/min) or vehicle for 2 weeks, and systolic blood pressure (SBP) was measured by tail cuff. Castration attenuated Ang II-induced increase in SBP in both Cyp1b1+/+ (184 ± 6 vs. 129 ± 4 mmHg, P < 0.05) and Cyp1b1-/- mice (150 ± 6 vs. 129 ± 4 mmHg, P < 0.05). In Cyp1b1+/+ mice, 6β-OHT did not alter Ang II-induced increase in SBP (184 ± 6 vs. 180 ± 8 mmHg, P < 0.05), but enhanced it in Cyp1b1-/- mice (150 ± 6 vs. 172 ± 8 mmHg, P < 0.05). Castration improved endothelial dysfunction associated with Ang II-induced hypertension in Cyp1b1+/+ mice, as demonstrated by increased relaxation of the aorta to acetylcholine. No endothelial dysfunction was observed in Cyp1b1-/- mice given Ang II with or without castration. In Cyp1b1+/+ mice, 6β-OHT did not alter Ang II-induced endothelial dysfunction, however, in Cyp1b1-/- mice infused with Ang II, 6β-OHT caused endothelial dysfunction. We have shown that Ang II-induced hypertension is associated with increased vascular production of reactive oxygen species (ROS) in Cyp1b1+/+ mice, and this increase is attenuated in Cyp1b1-/- mice, as measured by dihydroethidium fluorescence. In both Cyp1b1+/+ and Cyp1b1-/- mice given Ang II, castration abolished the increased ROS production. In Cyp1b1+/+ mice, 6β-OHT did not alter levels of ROS produced by Ang II, however, 6β-OHT further increased ROS production in Cyp1b1-/- mice given Ang II. These data suggest that 6β-OHT, a CYP1B1 metabolite of testosterone, contributes to the hypertensive effect of Ang II in male mice. Moreover, CYP1B1 could serve as a novel target for the development of agents for the treatment of androgen-mediated hypertension.

Download Full-text

Deficiency of T-type Ca2+ channels Cav3.1 and Cav3.2 has no effect on angiotensin II-induced hypertension but differential effect on plasma aldosterone in mice

AJP Renal Physiology ◽

10.1152/ajprenal.00121.2018 ◽

2019 ◽

Vol 317 (2) ◽

pp. F254-F263

Author(s):

Anne D. Thuesen ◽

Stine H. Finsen ◽

Louise L. Rasmussen ◽

Ditte C. Andersen ◽

Boye L. Jensen ◽

...

Keyword(s):

Blood Pressure ◽

Heart Rate ◽

Angiotensin Ii ◽

Cardiac Hypertrophy ◽

Natriuretic Peptide ◽

Mineralocorticoid Receptor ◽

Plasma Aldosterone ◽

Receptor Blocker ◽

Ang Ii ◽

Induced Hypertension

T-type Ca2+ channel Cav3.1 promotes microvessel contraction ex vivo. It was hypothesized that in vivo, functional deletion of Cav3.1, but not Cav3.2, protects mice against angiotensin II (ANG II)-induced hypertension. Mean arterial blood pressure (MAP) and heart rate were measured continuously with chronically indwelling catheters during infusion of ANG II (30 ng·kg−1·min−1, 7 days) in wild-type (WT), Cav3.1−/−, and Cav3.2−/− mice. Plasma aldosterone and renin concentrations were measured by radioimmunoassays. In a separate series, WT mice were infused with ANG II (100 ng·kg−1·min−1) with and without the mineralocorticoid receptor blocker canrenoate. Cav3.1−/− and Cav3.2−/− mice exhibited no baseline difference in MAP compared with WT mice, but day-night variation was blunted in both Cav3.1 and Cav3.2−/− mice. ANG II increased significantly MAP in WT, Cav3.1−/−, and Cav3.2−/− mice with no differences between genotypes. Heart rate was significantly lower in Cav3.1−/− and Cav3.2−/− mice compared with control mice. After ANG II infusion, plasma aldosterone concentration was significantly lower in Cav3.1−/− compared with Cav3.2−/− mice. In response to ANG II, fibrosis was observed in heart sections from both WT and Cav3.1−/− mice and while cardiac atrial natriuretic peptide mRNA was similar, the brain natriuretic peptide mRNA increase was mitigated in Cav3.1−/− mice ANG II at 100 ng/kg yielded elevated pressure and an increased heart weight-to-body weight ratio in WT mice. Cardiac hypertrophy, but not hypertension, was prevented by the mineralocorticoid receptor blocker canrenoate. In conclusion, T-type channels Cav3.1and Cav3.2 do not contribute to baseline blood pressure levels and ANG II-induced hypertension. Cav3.1, but not Cav3.2, contributes to aldosterone secretion. Aldosterone promotes cardiac hypertrophy during hypertension.

Download Full-text

A role for thyroid hormones in cold-induced elevation of blood pressure and cardiac hypertrophy

Canadian Journal of Physiology and Pharmacology ◽

10.1139/y94-149 ◽

1994 ◽

Vol 72 (9) ◽

pp. 1066-1074 ◽

Cited By ~ 8

Author(s):

Melvin J. Fregly ◽

Fabian Rossi ◽

J. Robert Cade

Keyword(s):

Blood Pressure ◽

Cardiac Hypertrophy ◽

Thyroid Hormones ◽

Antithyroid Drug ◽

Thyroid Stimulating Hormone ◽

Control Group ◽

Acute Administration ◽

Induced Hypertension ◽

Blood Pressures ◽

Stimulating Hormone

The systolic blood pressures of two groups of rats that were exposed to cold (5 °C) for 4 weeks were elevated significantly above that of warm-acclimated controls maintained at 24 °C. At this time these groups were given the antithyroid drug aminotriazole in their food at 0.3 g/kg. At the same time, one group was given 15.8 μg thyroxine (T4)/kg body mass per day, while the second received 31.6. The doses were chosen as replacement (15.8 μg/kg) and twice replacement (31.8 μg/kg) for the rats. The results of the study revealed that both groups receiving aminotriazole and T4 had reductions in blood pressure within 1 week of initiation of treatment. Blood pressures reached control level after 5 weeks. Cardiac hypertrophy accompanying cold-induced hypertension was reduced with the lower dose of T4 and prevented with the higher dose. Serum concentrations of T4 and triiodothyronine (T3) in the two treated groups were reduced, while serum thyroid-stimulating hormone concentration and thyroid mass were increased above that of the warm-acclimated control group. This suggests that the rats were hypothyroid relative to the warm-acclimated control group. However, the treated rats grew at the same rate as nontreated, cold-exposed controls and had similar food and water intakes, a similar dipsogenic response to acute administration of isoproterenol, and similar colonic temperatures. These measurements suggest that the rats were not functionally hypothyroid. Nevertheless, the results suggest that a paradigm in which the secretory ability of the thyroid gland is blocked, and T4 is returned at a constant, albeit suboptimal, level, reduced blood pressure and cardiac hypertrophy in cold-exposed rats. Hence, the increased turnover of thyroid hormones that characteristically accompanies exposure to cold plays a role in these changes. These studies also indicate that an increase in the rate of secretion of T4 is not required for survival in cold air.Key words: cold-induced hypertension, thyroxine, triiodothyronine, thyroid-stimulating hormone, aminotriazole, antithyroid drug, blood pressure, cardiac hypertrophy, catecholamines, norepinephrine, epinephrine, dopamine.

Download Full-text